Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Limited has submitted its Integrated Annual Report for FY 2024-25 along with the Notice for its 33rd Annual General Meeting, scheduled for Friday, September 26, 2025 at 12:00 noon via video conferencing. The Chairman's letter highlights a 22% topline growth and a return to positive adjusted EBITDA, backed by Rs 13.5 crore invested in talent, Rs 6 crore in digital marketing (yielding 7x growth in reach), and Rs 6 crore in capital expenditure on Ayurvedagram luxury rooms, clinic upgrades, and production equipment. The Ayurvedagram Bali centre grew 71% in FY25 while the Bengaluru retreat hit a record 90% occupancy. Looking ahead to FY26, the company plans 2x growth in India D2C, 3x growth in the US, the launch of a premium brand called 'Ruby Kerala Ayurveda,' a new Ayurvedagram property, and integration of Om Vedic Singapore and Bali JVs expected to add Rs 20 crore to revenue.
This is a routine annual report and AGM notice filing, so no immediate price impact is expected. The strong operational numbers (22% growth, return to positive EBITDA, robust resort occupancy) and a clear expansion roadmap may be viewed positively by existing shareholders and could support investor confidence in the stock.